Dr. David E. Kerr P S C | |
350 Calle Font Martelo Humacao PR 00791-3266 | |
(787) 852-8600 | |
(787) 852-7930 |
Full Name | Dr. David E. Kerr P S C |
---|---|
Speciality | Clinic/center - Dental |
Location | 350 Calle Font Martelo, Humacao, Puerto Rico |
Authorized Official Name and Position | David E. Kerr (PRESIDENT) |
Authorized Official Contact | 7878528600 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Dr. David E. Kerr P S C 350 Calle Font Martelo Humacao PR 00791-3266 Ph: (787) 852-8600 | Dr. David E. Kerr P S C 350 Calle Font Martelo Humacao PR 00791-3266 Ph: (787) 852-8600 |
NPI Number | 1285809574 |
---|---|
Provider Enumeration Date | 04/28/2008 |
Last Update Date | 04/28/2008 |
Identifier | Type | State | Issuer |
---|---|---|---|
1285809574 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QD0000X | Clinic/center - Dental | 1397 (Puerto Rico) | Primary |
News Archive
Traditionally PET imaging has been offered with one, two, three or even four rings of detectors with gaps between the rings. MR Solutions, the independent world leader in preclinical imaging, is now offering continuous PET detection thus avoiding any artifacts caused by the gaps between the rings.
A new multi-center study of 854 children with Crohn's disease shows a 5-year cumulative risk of bowel surgery is significantly lower than reported in recent studies. The findings of the study, led by Hasbro Children's Hospital, also indicate that children diagnosed between ages 13 and 16 had an increased risk of bowel surgery, and that a common treatment that begins at diagnosis, immunomodulator therapy, did not alter the risk of surgery.
Freezing a cancer kills it in its place, and also appears to generate an immune response that helps stop the cancer's spread, leading to improved survival rates over surgery, according to a new study in mice from researchers at the University of Michigan Comprehensive Cancer Center.
YM BioSciences Inc., announced the pre-publication of pivotal preclinical data for CYT387, the company's highly selective and potent JAK1/2 inhibitor, currently in a Phase I/II trial for myelofibrosis.
The U.S. Food and Drug Administration today approved Synribo (omacetaxine mepesuccinate) to treat adults with chronic myelogenous leukemia (CML), a blood and bone marrow disease.
› Verified 7 days ago
Centro Ortodontico Dra. Annelisse Figueroa Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 6 Urb Gomez, Humacao, PR 00791 Phone: 787-852-1550 Fax: 787-852-6798 | |
Centro Ortodontico Drs. Figueroa Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: Urb Gomez 6, Humacao, PR 00791 Phone: 787-852-1550 | |
Advance Dental Clinic Professional Corporation Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 52 Calle Dolores Cabrera Alonso E, Humacao, PR 00791 Phone: 787-850-1085 | |
Excelencia Dental, Psc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 61 Calle Antonio Lopez S Ste 1, Humacao, PR 00791 Phone: 787-852-6852 Fax: 787-852-0031 | |
Cavity Repair Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: Palmas Plantation, 122, Humacao, PR 00791 Phone: 787-515-7036 Fax: 787-885-0560 | |
Mv Orthodontics Psc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: B3 Repto Mendoza, Humacao, PR 00791 Phone: 787-850-2600 Fax: 787-850-7779 |